Lower levels of miR-374a were also detected in COVID-19 patients with respect to healthy controls, while its target, CCL2, is involved in acute respiratory distress syndrome (ARDS) and cytokine storms in COVID-19 patients. The gene discussed is CCL2; the disease is COVID-19.